Gilead Sciences · 15 hours ago
Postdoctoral Scientist - Human Cell Cycle
Gilead Sciences is focused on creating a healthier world by tackling diseases such as HIV and cancer. They are seeking a highly motivated Post-Doctoral Scientist to lead research on cell cycle mechanisms in cancer, collaborating closely with co-mentors and contributing to drug development efforts.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
The successful candidate will initiate and lead an independent research project to discover novel mechanisms that control the cell cycle under steady-state conditions and following pharmacological perturbations, elucidating how key cell cycle proteins interact to direct the cell cycle in cancer
Work with co-mentors to identify key questions in cancer cell cycle biology and independently draft research plans to answer these questions
Independently execute experiments, analyze data, and review results with co-mentors and the larger research community
Publish impactful findings in top-tier journals and present at scientific conferences
The selected candidate will work in a highly collaborative environment at Gilead through a 3-year fixed term, with access to world-class research facilities and the opportunity to leverage expertise and resources across multiple functional areas
Qualification
Required
Ph.D. (awarded or to be awarded within the next 6 months) in molecular biology, biochemistry, cancer biology or related field
First-author publication(s) in peer-reviewed journals
Think critically and creatively to independently design, execute, analyze, and communicate rigorous experimentation
Experience with cancer cell biology, biochemical methods and molecular biology desired
Preferred
Familiarity and hands on experience with the human cell cycle
Expertise in molecular biology, microscopy, CRISPR/Cas9, and omics-based approaches
Benefits
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Recent News
2026-01-16
FierceBiotech
2026-01-16
Company data provided by crunchbase